Source: Annual Congress 2005 - Treatment and monitoring of acute respiratory failure
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Rosenberg, A. Vlasenko, A. Bautin, V. Osovskikh, M. Tarasenko, I. Kozlov, V. Poptsov, V. Erockhin, Y. Zhilin, A. Seiliev, V. Volchkov (St. Petersburg, Moscow, Russian Federation). Efficiency of surfactant (ST) therapy for ALI/ARDS in homogenous nosologic groups of patients. Eur Respir J 2005; 26: Suppl. 49, 663

Member's Comments

No comment yet.

Related content which might interest you: Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease Source: International Congress 2019 – M-health/e-health I Year: 2019 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015 Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Estimation of tiotropium efficacy at the COPD patients with group D Source: International Congress 2015 – Different data in COPD Year: 2015 Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014 Length and clinical efficacy of pulmonary rehabilitation (PR) in COPD outpatients Source: Eur Respir J 2004; 24: Suppl. 48, 244s Year: 2004 Comparative assessment of hemodynamic parameters in patients with COPD and CHD treated with different groups of bronchodilators. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Noninvasive ventilation (NIV) in patients with Do-Not-Intubate (DNI) orders: efficacy critically depends on definitions Source: Eur Respir J 2005; 26: Suppl. 49, 443s Year: 2005 The types and frequency of mental disorders in COPD patients (pts) according to severity of COPD Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Indacaterol/glycopyrronium (IND/GLY) delays clinically important deterioration (CID) versus salmeterol/fluticasone (SFC) in symptomatic COPD patients: LANTERN/ILLUMINATE pooled analysis Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Clinical profile and characteristics of domiciliary ventilation in patients with overlap syndrome (COPD+OSAS) Source: Annual Congress 2010 - From the acute to the chronic patient: how do we use noninvasive ventilation? Year: 2010 Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Effectiveness of pulmonary rehabilitation including occupational therapy (OT) on the prognosis of patients with COPD Source: Annual Congress 2012 - New adjuncts and modalities in pulmonary rehabilitation Year: 2012 Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Treatment of advanced homogenous emphysema with endobronchial coils compared to NETT subjects who received LVRS or medical therapy Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014